Umirolimus
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-[(2R)-1-[(1S,3R,4R)-4-(2-ethoxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
Molecular Identity
Umirolimus
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-[(2R)-1-[(1S,3R,4R)-4-(2-ethoxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
PubChem CID: 11158972
2D Structure
Properties
C55H87NO14
Molecular Formula
986.30
Molecular Weight
g/mol
985.6127
Exact Mass
Da
6.8
XLogP
Above Lipinski threshold
194
TPSA
May have limited oral absorption
2
H-Bond Donors
14
H-Bond Acceptors
1840
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
UmirolimusBiolimus A9Biolimus851536-75-942-O-(2-ethoxyethyl) rapamycin40-O-(2-ethoxyethyl)rapamycinRapamycin, 42-O-(2-ethoxyethyl)-U36PGF65JHTRM986TRM 986umirolimusumDTXSID201026508RefChem:56816DTXCID601510682(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-((2R)-1-((1S,3R,4R)-4-(2-ethoxyethoxy)-3-methoxycyclohexyl)propan-2-yl)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Umirolimus
Loading drug network...